News from the healthcare data industry
Company enters into collaborations with leading next generation sequencing (NGS) companies to facilitate trial enrollment for PRECISION 1, the Company’s Phase 2 registrational trial Collaborations will expedite identification of advanced...
PREMIER registry to enroll a minimum of 750 patients and include all solid tumor cancers May 03, 2022 10:42 AM Eastern Daylight Time HAYWARD, Calif.–(BUSINESS WIRE)–RefleXion Medical, a therapeutic oncology...
Wednesday, May 04, 2022 – 07:00am NEW YORK, NY, May 4, 2022 – Pfizer Inc. (NYSE:PFE) announced today the presentation of real-world evidence demonstrating an associated benefit for patients treated...
– Medical chart review study, published in Drugs in Context, evaluated the real-world use of INOmax® (nitric oxide) gas, for inhalation in hospitalized COVID-19 patients with mild-to-moderate acute respiratory distress syndrome (ARDS) in...
Dive Brief: The Food and Drug Administration has approved the first drug to treat an ultra-rare cluster of conditions caused by mutations in a specific gene, granting an accelerated clearance to...
Sickle Cell Patients Treated With Endari® had Statistically Significantly Fewer Vaso-Occlusive Events and Hospitalizations Through 72 Weeks Follow-up, Versus Baseline Adverse Events Among These Patients from French Guiana and Qatar were Few and Mild TORRANCE,...
New studies demonstrate the ability of Foundation Medicine’s portfolio of tests to improve treatment options for patients, and reinforce the company’s role as an essential partner to researchers April 05,...
BOSTON, April 5, 2022 /PRNewswire/ — Researchers from Analysis Group, a global leader in health economics and outcomes research (HEOR), and AstraZeneca have published results from their ZEPHYR 1 study, the first real-world...
April 05, 2022 08:30 AM Eastern Daylight Time BOSTON–(BUSINESS WIRE)–PathAI, a global leader in AI-powered pathology, and GlaxoSmithKline (GSK), today announced a strategic multi-year partnership to accelerate scientific research and drug...
Analysis Suggests Use of RADICAVA IV is Associated with Improved Survival in People with ALS JERSEY CITY, N.J., April 4, 2022 /PRNewswire/ — Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced the...